Pfizer and Mexico sign agreement to manufacture and supply COVID-19 vaccine
MEXICO – The American pharmaceutical company Pfizer signed an agreement with the Mexican government, through the minister of Health, Jorge Alcocer Varela, for the manufacture and supply of a vaccine against the Sars-CoV-2 virus for the prevention of COVID-19 in Mexico, through which 34.4 million vaccines will be acquired.
According to information issued by the Mexican government, it is expected that in December 2020 the first 250,000 doses will be received for the start of vaccination against COVID-19 in Mexico, with priority on health personnel who are on the first line of attention to this disease.
The application of the vaccine, like others to which Mexico will have access under various schemes, will be governed by the National Policy on Vaccination against the Sars-CoV-2 virus for the prevention of COVID-19 in Mexico, which has as guiding principles promoting human well-being, equal access, equity, reciprocity.
In the next few days, this document will be released, which establishes the prioritization scheme, considering equity and universal access, and includes application criteria, pharmacovigilance, effectiveness and a communication strategy, among others.
Source: Cluster Industrial